Interleukin-4 receptor in moderate atopic asthma: A phase I/II randomized, placebo-controlled trial

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 6, 1999, Pages 1816-1823

  Borish, Larry C ^a,b   Nelson, Harold S ^a,b   Lanz, Miguel J ^a,b   Claussen, Lori ^a,b   Whitmore, James B ^a,b   Agosti, Jan M ^a,b   Garrison, Leslie ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRAKINCEPT; ANTIALLERGIC AGENT; IMMUNOGLOBULIN E; INTERLEUKIN 4 RECEPTOR; NITRIC OXIDE; RECOMBINANT RECEPTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY;

EID: 0033454115     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.6.9808146     Document Type: Article

References (35)

1. 1 and IgE synthesis by interleukin 4. J. Exp. Med. 167:183-196.
2. Pawankar, R., M. Okuda, H. Yssel, K. Okumura, and C. Ra. 1997. Nasal mast cells in perennial allergic rhinitis exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells [see comments]. J. Clin. Invest. 99:1492-1499.
3. Defrance, T., J. P. Aubry, F. Rousset, B. Vanbervliet, J. Y. Bonnefoy, N. Arai, Y. Takebe, T. Yokota, F. Lee, K. Arai, J. DeVries, and J. Banchereau. 1987. Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J. Exp. Med. 165:1459-1467.
4. Vercelli, D., H. H. Jabara, B. W. Lee, N. Woodland, R. S. Geha, and D. Y. Leung. 1988. Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. J. Exp. Med. 167:1406-1416.
5. Schleimer, R. P., S. A. Sterbinsky, J. Kaiser, C. A. Bickel, D. A. Klunk, K. Tomioka, W. Newman, F. W. Luscinskas, M. A. Gimbrone, Jr., B. W. McIntyre, and B. S. Bochner. 1992. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J. Immunol. 148:1086-1092.
6. Moser, R., J. Fehr, and P. L. Bruijnzeel. 1992. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J. Immunol. 149:1432-1438.
7. Abehsira-Amar, O., M. Gibert, M. Joliy, J. Theze, and D. L. Jankovic. 1992. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J. Immunol. 148:3820-3829.
8. Seder, R. A., W. E. Paul, M. M. Davis, and B. Fazekas de St. Groth. 1992. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091-1098.
9. Idzerda, R. L., C. J. March, B. Mosley, S. D. Lyman, T. Vanden Bos, S. D. Gimpel, W. S. Din, K. H. Grabstein, M. B. Widmer, L. S. Park, D. Cosman, and M. P. Beckman. 1990. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 171:861-873.
10. Yin, T., M. L. Tsang, and Y. C. Yang. 1994. JAKI kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J. Biol. Chem. 269:26614-26617.
11. 1 production by soluble IL-4 receptor. Int. Arch. Allergy Immunol. 106:46-54.
12. Gillings, D., and G. Koch. 1991. The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Info. J. 25:411-424.
13. Lewis, D. B., H. D. Liggitt, E. L. Effmann, S. T. Motley, S. L. Teitelbaum, K. J. Jepsen, S. A. Goldstein, J. Bonadio, J. Carpenter, and R. M. Perlmutter. 1993. Osteoporosis induced in mice by overproduction of interleukin 4. Proc. Natl. Acad. Sci. U.S.A. 90:11618-11622.
14. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258-2261.
15. Grunig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-2263.
16. Kopf, M., G. Le Gros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248.
17. Parronchi, P., M. De Carli, R. Manetti, C. Simonelli, S. Sampognaro, M. P. Piccinni, D. Macchia, E. Maggi, G. Del Prete, and S. Romagnani. 1992. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149:2977-2983.
18. Coyle, A. J., G. Le Gros, C. Bertrand, S. Tsuyuki, C. H. Heusser, M. Kopf, and G. P. Anderson. 1995. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am. J. Respir. Cell Mol. Biol. 13:54-59.
19. Kurup, V. P., P. S. Murali, J. Guo, H. Choi, B. Banerjee, J. N. Fink, and R. L. Coffman. 1997. Anti-interleukin (IL)-4 and -IL-5 antibodies down-regulate IgE and eosinophilia in mice exposed to Aspergillus antigens. Allergy 52:1215-1221.
20. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
21. Hogan, S. P., A. Mould, H. Kikutani, A. J. Ramsay, and P. S. Foster. 1997. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest. 99:1329-1339.
22. Kips, J. C., G. G. Brusselle, G. F. Joos, R. A. Peleman, R. R. Devos, J. H. Tavernier, and R. A. Pauwels. 1995. Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int. Arch. Allergy Immunol. 107:115-118.
23. Pearce, E. J., A. Cheever, S. Leonard, M. Covalesky, R. Fernandez-Botran, G. Kohler, and M. Kopf. 1996. Schistosomiasis mansoni in IL-4-deficient mice. Int. Immunol. 8:435-444.
24. Kopf, M., G. Le Gros, A. J. Coyle, M. Kosco-Vilbois, and F. Brombacher. 1995. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol. Rev. 148:45-69.
25. Sato, T. A., M. B. Widmer, F. D. Finkelman, H. Madani, C. A. Jacobs, K. H. Grabstein, and C. R. Maliszewski. 1993. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 150:2717-2723.
26. Bergese, S. D., E. H. Huang, R. P. Pelletier, M. B. Widmer, R. M. Ferguson, and C. G. Orosz. 1995. Regulation of endothelial VCAM-1 expression in murine cardiac grafts: expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection. Am. J. Pathol. 147:166-175.
27. Cenci, E., S. Perito, K. H. Enssle, P. Mosci, J. P. Latge, L. Romani, and F. Bistoni. 1997. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect. Immun. 65:564-570.
28. Puccetti, P., A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, K. H. Enssle, L. Romani, and F. Bistoni. 1994. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis. 169:1325-1331.
29. Cenci, E., A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K. H. Enssle, P. Puccetti, L. Romani, and F. Bistoni. 1995. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1279-1288.
30. Renz, H., K. Bradley, K. Enssle, J. E. Loader, G. L. Larsen, and E. W. Gelfand. 1996. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Int. Arch. Allergy Immunol. 109:167-176.
31. Maliszewski, C. R., T. A. Sato, T. Vanden Bos, S. Waugh, S. K. Dower, J. Slack, M. P. Beckmann, and K. H. Grabstein. 1990. Cytokine receptors and B cell functions: I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro. J. Immunol. 144:3028-3033.
32. Maliszewski, C. R., P. J. Morrissey, W. C. Fanslow, T. A. Sato, C. Willis, and B. Davison. 1992. Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor. Cell. Immunol. 143:434-448.
33. Urban, J. F., Jr., N. Noben-Trauth, D. D. Donaldson, K. B. Madden, S. C. Morris, M. Collins, and F. D. Finkelman. 1998. IL-13, IL-4R alpha and Stat6 are required for expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8:255-264.
34. Barner, M., M. Mohrs, F. Brombacher, and M. Kopf. 1998. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 8:669-672.
35. Urban, J., Jr., I. M. Katona, W. E. Paul, and F. D. Finkelman. 1991. Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc. Natl. Acad. Sci. U.S.A. 88:5513-5517.